Pfizer and partner BioNTech said Tuesday they have asked the EU to approve their coronavirus vaccine.
Moderna also filed for EU authorization of its COVID-19 vaccine.
Both vaccines were supposed to be assessed December 22, but this has been pushed back by the EU's regulator, according to documents seen by the FT.
Regulator the European Medicines Agency said in a press release that it might not decide whether Pfizer's COVID-19 vaccine is safe and effective enough until December 29. Approval on that date would make an EU vaccine rollout this year almost impossible.
The final date for a decision Moderna's vaccine has been delayed until January 12, per the Financial Times.